Gene · 8764
Papers3,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 3,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of six hub genes in mantle cell lymphoma patients with BTKi resistance. | Ann Transl Med | 2022 | 36388812 | PubTator, text mining | PubMed |
| The Cuproptosis-Related Long Noncoding RNA Signature Predicts Prognosis and Tumour Immune Analysis in Osteosarcoma. | Comput Math Methods Med | 2022 | 36388161 | PubTator, text mining | PubMed |
| Noncoding RNA-mediated regulation of pyroptotic cell death in cancer. | Front Oncol | 2022 | 36387211 | PubTator, text mining | PubMed |
| Expression profile and prognostic values of LSM family in skin cutaneous melanoma. | BMC Med Genomics | 2022 | 36371223 | PubTator, text mining | PubMed |
| Tumor-Associated Lymphatics Upregulate MHC-II to Suppress Tumor-Infiltrating Lymphocytes. | Int J Mol Sci | 2022 | 36362253 | PubTator, text mining | PubMed |
| The Proliferative Role of Immune Checkpoints in Tumors: Double Regulation. | Cancers (Basel) | 2022 | 36358792 | PubTator, text mining | PubMed |
| Artificial Intelligence Predicted Overall Survival and Classified Mature B-Cell Neoplasms Based on Immuno-Oncology and Immune Checkpoint Panels. | Cancers (Basel) | 2022 | 36358737 | PubTator, text mining | PubMed |
| Panel Sequencing of Primary Cutaneous B-Cell Lymphoma. | Cancers (Basel) | 2022 | 36358692 | PubTator, text mining | PubMed |
| Pan-cancer analysis of UBE2T with a focus on prognostic and immunological roles in lung adenocarcinoma. | Respir Res | 2022 | 36357897 | PubTator, text mining | PubMed |
| Single-cell profiling reveals a memory B cell-like subtype of follicular lymphoma with increased transformation risk. | Nat Commun | 2022 | 36351924 | PubTator, text mining | PubMed |
| LAMP3/CD63 Expression in Early and Late Endosomes in Human Vaginal Epithelial Cells Is Associated with Enhancement of HSV-2 Infection. | J Virol | 2022 | 36350153 | PubTator, text mining | PubMed |
| Dual Roles of Tumor Necrosis Factor Superfamily 14 in Antiviral Immunity. | Viral Immunol | 2022 | 36342780 | PubTator, text mining | PubMed |
| Comprehensive characterization of TNFSF14/LIGHT with implications in prognosis and immunotherapy of human gliomas. | Front Immunol | 2022 | 36341396 | PubTator, text mining | PubMed |
| Construction of N-7 methylguanine-related mRNA prognostic model in uterine corpus endometrial carcinoma based on multi-omics data and immune-related analysis. | Sci Rep | 2022 | 36335189 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals rebalancing of immunological response in patients with periodontitis after non-surgical periodontal therapy. | J Transl Med | 2022 | 36329504 | PubTator, text mining | PubMed |
| The 48th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians - Oral Sessions (O009-O155). | Bone Marrow Transplant | 2022 | 36323939 | PubTator, text mining | PubMed |
| A novel cuproptosis-related immune checkpoint gene signature identification and experimental validation in hepatocellular carcinoma. | Sci Rep | 2022 | 36323801 | PubTator, text mining | PubMed |
| Tumor Microenvironment in Hepatocellular Carcinoma: Key Players for Immunotherapy. | J Hepatocell Carcinoma | 2022 | 36320666 | PubTator, text mining | PubMed |
| Deciphering molecular and cellular ex vivo responses to bispecific antibodies PD1-TIM3 and PD1-LAG3 in human tumors. | J Immunother Cancer | 2022 | 36319064 | PubTator, text mining | PubMed |
| Comprehensive Molecular Analyses of an SLC Family-Based Model in Stomach Adenocarcinoma. | Pathol Oncol Res | 2022 | 36313898 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8764/papers?page=46